八种不同的基因多态对土耳其人口骨质疏松症和骨质疏松症的影响
Naim Uzun1, Ahmet Kiziltunc2, Adem Keskin3,4
1Agri Ibrahim Cecen University, Faculty of Pharmacy, Department of Clinical Pharmacy, Department of Pharmacy Vocational Sciences - Ağrı, Turkey.
概括
骨质保护素G209A基因变异可能会增加土耳其人口的骨质疏松症和骨质疏松症风险. 其他分析的基因变异与这些骨密度条件没有显著的关联.
科学领域:
- 遗传学 遗传学 是一个
- 骨的新陈代谢 骨的新陈代谢
- 骨质疏松症研究 骨质疏松症研究
背景情况:
- 骨矿物质密度受到多个基因的影响,骨质疏松症是由骨矿物质密度下降引起的.
- 骨质疏松症和骨质疏松症具有复杂,多遗传和多因素的发病过程.
- 了解遗传贡献对于识别疾病风险因素至关重要.
研究的目的:
- 研究特定基因变异与骨矿物质密度之间的关联.
- 检查诊断为骨质疏松症或骨质疏松症的个体中八个基因区域的作用.
- 为了确定遗传变异是否有助于患上这些骨疾病的风险.
主要方法:
- 60名骨质疏松症患者,50名骨质疏松症患者和40名健康对照者的基因定型.
- 对基因变异的分析,包括原蛋白I型α-1,雌激素受体α,维生素D受体,乳糖酶,骨质保护素和介素-6.
- 基因变异分布在患者和对照组之间的统计比较.
主要成果:
- 两组之间没有发现原I型α1,雌激素受体α,维生素D受体,乳糖酶,骨质保护素T245G和素-6基因变异的显著差异.
- 在患者组和对照组之间观察到骨质保护素G209A基因变异分布的显著差异.
- 在骨质疏松症和骨质疏松症患者组之间,没有发现骨质保护素G209A基因变异分布的显著差异.
结论:
- 骨质保护素G209A基因变异可能与土耳其人口中骨质疏松症和骨质疏松症的风险有关.
- 除了骨质保护素G209A之外,分析的基因变异没有显示与骨质疏松症或骨质疏松症风险的关联.
- 需要进一步的研究来阐明骨质保护素G209A在骨健康中的确切作用.
相关概念视频
Bone Disorders
3.3K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.3K
Bone Remodeling
38.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.0K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Hormones and Bone Tissue
2.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
What is the Skeletal System?
51.9K
Overview
51.9K
Oogenesis
63.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.1K


